Goodwin advised TCR² Therapeutics Inc. on the deal while Ropes & Gray represented Adaptimmune Therapeutics plc. TCR² Therapeutics Inc. (NASDAQ: TCRR) announced its definitive agreement with Adaptimmune...
TCR² Therapeutics’ Agreement with Adaptimmune Therapeutics
GHO Capital and The Vistria Group’s Acquisition of Alcami
Ropes & Gray represented GHO Capital and The Vistria Group, while Kirkland & Ellis represented Alcami in the transaction. GHO Capital and The Vistria Group announced...
RoslinCT’s Merger with Lykan Bioscience
Ropes & Gray and Slaughter & May acted as legal advisors to GHO, while McDermott Will & Emery LLP advised WindRose Health Investors, LLC. RoslinCT entered into...
Pfizer’s Acquisition of Biohaven Pharmaceutical
Ropes & Gray, working alongside Walkers, represented Pfizer, while Skadden advised Centerview Partners, the financial advisor to Biohaven Pharmaceutical on the deal. S&C, Maples and Calder...
Pfizer’s $6.7 Billion Acquisition of Arena Pharmaceuticals
Ropes & Gray advised Pfizer Inc. in the deal, while Cooley represented Arena Pharmaceuticals. Debevoise & Plimpton advised Evercore Group and Guggenheim Securities as financial advisors...
The Vistria Group’s Acquisition of BioCare
Ropes & Gray represented The Vistria Group on the transaction. The Vistria Group executed its acquisition of BioCare, Inc. Terms of the transaction were not disclosed. BioCare...